CS
BPTH

Credit Suisse’s Bio-Path Holdings Inc BPTH Stock Holding History

Credit Suisse’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3
Closed -$11K – 3994
2017
Q1 		$11K Sell
3
-5
-63% -$18.2K ﹤0.01% 3774
2016
Q4 		$46K Hold
8
– – ﹤0.01% 4028
2016
Q3 		$47K Sell
8
-1
-11% -$6.42K ﹤0.01% 4025
2016
Q2 		$70K Hold
9
– – ﹤0.01% 4114
2016
Q1 		$89K Buy
9
+5
+125% +$32.4K ﹤0.01% 3837
2015
Q4 		$22K Buy
+4
New +$23.3K ﹤0.01% 4171
2015
Q3 		– Sell
-33
Closed -$153K – 4535
2015
Q2 		$153K Buy
33
+29
+725% +$159K ﹤0.01% 4306
2015
Q1 		$27K Sell
4
-5
-56% -$42K ﹤0.01% 4311
2014
Q4 		$92K Buy
9
+4
+80% +$41.3K ﹤0.01% 4449
2014
Q3 		$40K Sell
5
-6
-55% -$57.9K ﹤0.01% 4366
2014
Q2 		$132K Buy
+11
New +$121K ﹤0.01% 4491

Other funds holding BPTH

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCA
Rowland Carmichael Advisors Scottsdale, Arizona $316M AUM 18.07% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Credit Suisse's BPTH Position: Q2 2017 in Review

Credit Suisse sold out of Bio-Path Holdings Inc (BPTH) in Q2 2017, closing a stake of 3 shares — an estimated $11K sold.

Credit Suisse first reported a position in BPTH in Q2 2014 and held it in 11 quarters. The position peaked at $153K in Q2 2015. 33 funds tracked by Wall St. Rank hold BPTH as of Q2 2017.

  • Credit Suisse reported no remaining Bio-Path Holdings Inc position as of Q2 2017 after selling out during the quarter.
  • Credit Suisse sold 3 Bio-Path Holdings Inc shares in Q2 2017, an estimated $11K.
  • Credit Suisse first reported a position in Bio-Path Holdings Inc in Q2 2014 and held it in 11 quarters.
  • Credit Suisse's Bio-Path Holdings Inc position peaked at $153K in Q2 2015.
  • 33 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2017.

Based on Credit Suisse's 13F filing for Q2 2017, filed 14 Aug 2017.